Erythrodermic psoriasis eruption associated with SARS-CoV-2 vaccination.
Nia AM, Silva MM, Spaude J, Gonzalez-Fraga JD.
Dermatol Ther. 2022 May;35(5):e15380. doi: 10.1111/dth.15380. Epub 2022 Mar 1.
Cutaneous Drug Reactions in the Elderly.
Young JWS, Shear NH.
Drugs Aging. 2017 Sep;34(9):655-672. doi: 10.1007/s40266-017-0483-5.
Sofosbuvir-Induced Erythrodermic Pityriasis Rubra Pilaris-Like Drug Eruption.
Cheung EJ, Jedrych JJ, English JC 3rd.
J Drugs Dermatol. 2015 Oct;14(10):1161-2.
A case of erythema multiforme drug eruption associated with erythrodermic psoriasis induced by sofosbuvir and daclatasvir.
Wang Y, Liu P.
J Clin Pharm Ther. 2017 Feb;42(1):108-110. doi: 10.1111/jcpt.12467. Epub 2016 Oct 18.
Erythrodermic drug eruption due to roxatidine acetate hydrochloride.
Igawa K, Matsunaga T, Yokozeki H, Nishioka K.
Clin Exp Dermatol. 2005 May;30(3):304-5. doi: 10.1111/j.1365-2230.2005.01755.x.
Erythrodermic psoriasis.
Brenner S, Wolf R.
J Am Acad Dermatol. 1991 Feb;24(2 Pt 1):324. doi: 10.1016/s0190-9622(08)80643-3.
Secukinumab Therapy for Netherton Syndrome.
Luchsinger I, Knöpfel N, Theiler M, Bonnet des Claustres M, Barbieux C, Schwieger-Briel A, Brunner C, Donghi D, Buettcher M, Meier-Schiesser B, Hovnanian A, Weibel L.
JAMA Dermatol. 2020 Aug 1;156(8):907-911. doi: 10.1001/jamadermatol.2020.1019.
Transient eruptive seborrheic keratoses associated with erythrodermic psoriasis and erythrodermic drug eruption: report of two cases.
Flugman SL, McClain SA, Clark RA.
J Am Acad Dermatol. 2001 Dec;45(6 Suppl):S212-4. doi: 10.1067/mjd.2001.103641.
Erythrodermic Bullous Pemphigoid in Skin of Color Treated With Dupilumab.
Sanfilippo E, Gonzalez Lopez A, Saardi KM.
J Drugs Dermatol. 2023 Jul 1;22(7):685-686. doi: 10.36849/JDD.7196.
Prognosis after Hospitalization for Erythroderma.
Egeberg A, Thyssen JP, Gislason GH, Skov L.
Acta Derm Venereol. 2016 Nov 2;96(7):959-962. doi: 10.2340/00015555-2445.
